-- UltraGreen.ai (SGX:ULG) was granted regulatory approval in Singapore for Verdye, an indocyanine green injection, according to a Tuesday filing with the Singapore Exchange.
The approval allows the company to ramp up its commercialization efforts and expand its partnerships with local healthcare institutions as part of the adoption of its fluorescence-guided technology.
The technology is used across multiple surgical procedures.
Shares of the healthcare intelligence company were down over 5% in Tuesday's late-morning trade.